By Therapeutic Area

Corneal Exposure & Lagophthalmos Management Market Analysis

Cross-industry research covering Corneal Exposure & Lagophthalmos Management across 1 market reportspanning Pharmaceuticals & Medical Devices — Ophthalmic Surgery.

1 Reports
1 Industries

Reports Covering Corneal Exposure & Lagophthalmos Management

Oculoplastic Surgery Market to Reach USD 8.4 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Medical Devices — Ophthalmic Surgery·Market: USD 4.8 Billion (2025)·CAGR: 7.2%

Paralytic lagophthalmos secondary to facial nerve palsy drives most volume; an active trial of a self-adhering magnetic device for tarsorrhaphy (NCT06291818, University of Illinois at Chicago) suggests device-based management may reduce dependence on lubricant pharmacotherapy in this segment.

9%

Market Share

6.7%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments